SIGNAL Group (formerly McBee Strategic Consulting, LLC) is a wholly owned subsidiary of Wiley Rein. SIGNAL is a total solutions provider—advocacy, strategic communications, research, and digital media—for clients seeking to engage the federal government to achieve competitive advantage, influence public policy, establish new markets, and secure public capital.

Wiley Rein Bolsters Its Intellectual Property Practice with the Addition of Biotech Patent Group

February 2014

Wiley Rein is pleased to announce that A. Neal Seth, Lawrence M. Sung, and Mary Sylvia have joined the firm as partners in its esteemed Intellectual Property Practice. The team—which brings a dynamic combination of scientific credentials and legal acumen—will advise clients on patent litigation strategy and appeals, patent prosecution and portfolio matters, dispute settlements, and technology transfer in the biotechnology, pharmaceutical, medical devices, and chemical industries.

The group, which comes to Wiley Rein from BakerHostetler, has a diverse background serving major companies, as well as start-ups. All three partners are registered patent attorneys. Mr. Seth focuses on patent litigation and appeals. Mr. Sung has 20 years of experience in patent counseling, litigation, and technology transfer. Ms. Sylvia has nearly 30 years of experience in microbiology and patent law and was trained as a molecular biologist.

“We are pleased to welcome these talented lawyers to our firm,” said Chairman Richard E. Wiley. “Their outstanding accomplishments and deep patent experience in the fast-growing life sciences and biotech sectors will greatly benefit our clients.”